According to the report, 2026 venture funding remains healthy so far, with $7.4B across 244 deals raised in H1 2026 and $3.2B of that total coming in Q2, the median deal size increasing to $14M in 1H 2026 (from $12M in 2025) and 20 mega deals in H1, representing 45% of all capital invested.

But the market has entered a new phase of maturity: investors are no longer chasing the next shiny technology. Instead, they’re rewarding companies that can demonstrate measurable impact, sustainable growth and strong commercial execution.

That shift should fundamentally influence how healthcare organizations communicate their value in the current market.

Evidence has become the strongest marketing asset

Buyers, investors and partners increasingly expect proof—not promises. Clinical outcomes, customer success stories, peer-reviewed research, economic value and implementation results carry significantly more weight than aspirational messaging. Organizations that can clearly demonstrate measurable impact will stand apart in a crowded market.

AI alone is no longer a headline

Over the past two years, simply mentioning artificial intelligence generated attention. Today, audiences assume AI capabilities exist. The experimental and beta phases are in the past. AI has now been integrated into everyday workflows, particularly around administrative tasks, clinical documentation, revenue cycle management and patient engagement, with the current focus on scaling AI responsibly, proving return on investment and embedding it into routine care delivery.

The more compelling story is how AI improves clinician workflows, reduces administrative burden, improves patient outcomes or creates measurable operational efficiencies. The technology itself is becoming less interesting than the outcomes it enables.

Trust has become a competitive advantage

As healthcare purchasing decisions become increasingly evidence-driven, marketing and communications teams play an essential role in building credibility. Thought leadership, transparent data, customer validation and consistent storytelling all contribute to the confidence that buyers and investors seek.

So, what can healthcare marketers and communicators be doing to effectively navigate brands through the churning waters of the remainder of 2026?

• Lead with outcomes, not features. Showcase measurable clinical, financial or operational impact before discussing technology.
• Turn validation into content. Peer-reviewed studies, customer case studies, implementation data and analyst recognition should fuel an ongoing, multi-channel content strategy rather than remain confined to the four walls of the company or to an arbitrary press release from time to time.
• Increase reach and frequency. Strategically devise and execute a multi-channel program that will reach and engage key stakeholders and decision-makers. Be creative—think a mix of shareables, videos, podcasts, influencers, paid and organic social, sponsorships, earned media and content to reach audiences via the channels they use to get information.
• Build a reputation, not just awareness. The companies attracting attention today are those that consistently demonstrate expertise, reliability and measurable value at every touchpoint.

Rock Health’s report reinforces a simple reality: The healthcare innovation market has entered a more mature chapter. Companies are no longer competing solely on vision—they’re competing on validation. For marketing and communications leaders, that’s good news, and success will come from helping companies prove, not just proclaim, their value. In today’s environment, credibility has become one of the most powerful differentiators a healthcare brand can build. Organizations that can consistently tell evidence-based stories, elevate credible voices and demonstrate measurable impact will earn attention and trust. And in today’s healthcare market, trust may be the most valuable differentiator of all.

Interested in building trust and credibility for your healthcare, healthIT, or pharmatech brand to take it to the next level of growth? Looking for a team that places a premium on strategy, market knowledge, communications expertise and creative storytelling…and are good people to work with? Get in touch! And, see why we have been the chosen partner of hundreds of healthcare brands.

Dan Martin is Executive Vice President, Healthcare Technology Practice Lead at V2 Communications, where he partners with healthcare innovators to build market awareness, establish credibility and accelerate business growth through strategic communications. With decades of experience advising digital health, health IT, diagnostics and care delivery companies, Dan specializes in translating complex healthcare innovations into compelling narratives that resonate with providers, payers, investors and the broader market.

About V2 Communications

V2 Communications is a top PR firm for tech companies and a leading integrated communications partner focused on healthcare, B2B technology, AI, climate and energy and other high-growth brands. The firm delivers integrated communications programs across earned, owned, and paid media, helping companies build market leadership, increase visibility, and drive measurable business results.